Abstract
Purpose
To report the reproducibility, sensitivity, specificity, and predictive value of home monitoring for disease activity in neovascular age-related macular degeneration (ARMD).
Methods
Participants were trained to complete three separate home monitoring tasks, designed to identify subtle changes in visual function that may indicate increasing neovascular ARMD disease activity. These included measurement of near acuity and assessments of environmental distortion and overall visual function. The need for repeat intra-vitreal injection, as predicted by home monitoring, was compared to standard clinical assessment involving ETDRS distance acuity, slit lamp examination, and spectral domain ocular coherence tomography.
Results
Although all participants were able to complete the home monitoring tasks, the reproducibility of each of the three tasks was modest. Cohen’s kappa was 0.118 (p = 0.54) for the comparison of the outcome of the home monitoring exercise with the gold standard of hospital assessment to determine disease activity. The sensitivity of the home monitoring exercise was 33.3 % (95 % CI 15.2–51.4) and the specificity was 77.8 % (95 % CI 61.8–93.8).
Conclusions
This study suggests that current tests of visual function, which are readily completed at home, cannot replace traditional clinic-based assessments for neovascular ARMD disease activity. Instead, such tests are likely to remain complementary to standard assessment in clinic.
Similar content being viewed by others
References
Brown C, Xing W, Wormald R (2010) Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008. Eye (Lond) 24(11):1692–1699
Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T et al (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 116(1):57–65
Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355(14):1419–1431
Mitchell P, Korobelnik JF, Lanzetta P, Holz FG, Prünte C, Schmidt-Erfurth U et al (2010) Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol 94(1):2–13
Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W et al (2009) A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 148(1):43–58
Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ et al (2012) Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology 119(7):1388–1398
IVAN Study Investigators, Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ et al (2012) Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology 119(7):1399–1411
Fleiss JL (1971) Measuring nominal scale agreement among many raters. Psychol Bull 76(5):378–382
Bartko JJ (1966) The intra-class correlation coefficient as a measure of reliability. Psychol Rep 19(1):3–11
Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20(1):37–46
Faes L, Bodmer NS, Bachmann LM, Thiel MA, Schmid MK (2014) Diagnostic accuracy of the Amsler grid and the preferential hyperacuity perimetry in the screening of patients with age-related macular degeneration: systematic review and meta-analysis. Eye (Lond) 28(7):788–796
Mathew R, Sivaprasad S (2012) Environmental Amsler test as a monitoring tool for retreatment with ranibizumab for neovascular age-related macular degeneration. Eye 26:389–393
Wang YZ, He YG, Mitzel G, Zhang S, Bartlett M (2013) Handheld shape discrimination hyperacuity test on a mobile device for remote monitoring of visual function in maculopathy. Invest Ophthalmol Vis Sci 54(8):5497–5505
Weymouth AE, McKendrick AM (2012) Shape perception is altered by normal aging. Invest Ophthalmol Vis Sci 53(6):3226–3233
Trevino R, Kynn MG (2008) Macular function surveillance revisited. Optometry 79(7):397–403
Fletcher DC, Schuchard RA (2006) Visual function in patients with choroidal neovascularization resulting from age-related macular degeneration: the importance of looking beyond visual acuity. Optom Vis Sci 83:178–189
Loewenstein A, Malach R, Goldstein M, Leibovitch I, Barak A, Baruch E et al (2003) Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration. Ophthalmology 110(5):966–970
The AREDS2-HOME Study Research Group, Chew WC, Clemons TE, Bressler SB, Elman MJ, Danis RP et al (2014) Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study. Ophthalmology 121(2):535–544
Das R, Shi Y, Silvestri G, Chakravarty U (2009) Distortion maps from preferential hyperacuity perimetry are helpful in monitoring functional response to Lucentis therapy. Retina 29:1013–1018
Querques G, Querques L, Rafaeli O, Canoui-Poitrine F, Bandello F, Souied EH (2011) Preferential hyperacuity perimeter as a functional tool for monitoring exudative age-related macular degeneration in patients treated by intravitreal ranibizumab. Invest Ophthalmol Vis Sci 52(9):7012–7018
Kaiser PK, Wang YZ, He YG, Weisberger A, Wolf S, Smith CH (2013) Feasibility of a novel remote daily monitoring system for age-related macular degeneration using mobile handheld devices: results of a pilot study. Retina 33(9):1863–1870
Acknowledgments
This project was supported by an award from the Biomedical Health Research Centre Problem Solving Fund (PSF87).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McKibbin, M., Baker, L., Baxter, P. et al. The accuracy of home monitoring to detect disease activity during maintenance therapy for neovascular ARMD. Graefes Arch Clin Exp Ophthalmol 253, 1479–1483 (2015). https://doi.org/10.1007/s00417-014-2839-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-014-2839-4